Biosynthema Overview
- Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Biosynthema General Information
Description
Provider of drug development and discovery services. The company develops and researches on radiopharmaceuticals for diagnostic and therapeutic applications.
Contact Information
Website
www.biosynthema.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Primary Office
- 4041 Forest Park Avenue
- Saint Louis, MO 63108
- United States
+1 (314) 000-0000
Biosynthema Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biosynthema Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jack Erion Ph.D | President and Chief Executive Officer |